{"id": "1381880045996740609", "creation": 1618300851.0, "user_id": "2752355256", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "An inactivated #Covid19 #vaccine developed by @valnevaSE showed promise in a phase I/II trial, causing more than 90% of the participants to produce antibodies against the SARS-CoV-2 virus. The company aims to launch a phase III trial by the end of April.\ud83e\udda0 https://t.co/G0Tfldbxv3 https://t.co/g3v2rULBWl", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}